![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Author: Zhu Bo-qing Zhou Hui-zhong Teerlink John Karliner Joel
Publisher: Springer Publishing Company
ISSN: 0920-3206
Source: Cardiovascular Drugs and Therapy, Vol.18, Iss.6, 2004-11, pp. : 421-431
Disclaimer: Any content in publications that violate the sovereignty, the constitution or regulations of the PRC is not accepted or approved by CNPIEC.
Abstract
Related content
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Busk Martin Maeng Michael Kristensen Jens Berg Jette Mortensen Ulrik Nielsen Torsten Nielsen-Kudsk Jens
Cardiovascular Drugs and Therapy, Vol. 20, Iss. 5, 2006-10 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
By Yilmaz M.
Naunyn-Schmiedeberg's Archives of Pharmacology, Vol. 378, Iss. 3, 2008-09 ,pp. :
![](/images/ico/ico_close.png)
![](/images/ico/ico5.png)
Clarithromycin attenuates myocardial ischemia–reperfusion injury
By Nakajima Takuya Hishikari Keiichi Ogawa Masahito Watanabe Ryo Suzuki Jun-ichi Nagashima Ayako Masumura Mayumi Takayama Kiyoshi Hirata Yasunobu Nagai Ryozo Isobe Mitsuaki
Expert Opinion on Therapeutic Targets, Vol. 14, Iss. 9, 2010-09 ,pp. :